Robert J. Hugin

Chief Financial Officer, CELGENE CORP /DE/.

Companies

Biohaven PharmaceuticalsBoard member Sep 30, 2022 to now¹
Chubb Corp.Board member May 21, 2020 to now²
Biohaven Pharmaceutical Holding Co Ltd.Board member Jun 12, 2020 to Oct 3, 2022³
Allergan plcBoard member Feb 20, 2019 to May 11, 2020⁴
Danaher CorporationBoard member Jul 15, 2016 to May 17, 2017⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 21, 2026Granted 1,135 shares of Chubb Corp.⁶
May 15, 2025Granted 1,284 shares of Chubb Corp.⁹
May 16, 2024Granted 1,227 shares of Chubb Corp.¹⁰
May 17, 2023Granted 1,634 shares of Chubb Corp.¹¹
Oct 3, 2022Shares withheld for tax 3,263 shares at $7.50 of Biohaven Pharmaceuticals¹²
Oct 3, 2022Exercised options 9,474 shares at $3.39 of Biohaven Pharmaceuticals¹²
Oct 3, 2022Exercised options 5,998 shares at $3.56 of Biohaven Pharmaceuticals¹²
Oct 3, 2022Exercised options 4,119 shares at $4.84 of Biohaven Pharmaceuticals¹²
Oct 3, 2022Other 1,708 shares of Biohaven Pharmaceuticals¹²
Oct 3, 2022Returned to company 2,900 shares at $148.50 of Biohaven Pharmaceutical Holding Co Ltd.⁸
Oct 3, 2022Shares withheld for tax 12,959 shares at $7.50 of Biohaven Pharmaceuticals⁷
Oct 3, 2022Other 1,450 shares of Biohaven Pharmaceuticals¹²
May 19, 2022Granted 1,594 shares of Chubb Corp.¹³

The numbers on this page point here. Each one links to the record it came from.